These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of Langerhans cell histiocytosis in children with etoposide. Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115 [TBL] [Abstract][Full Text] [Related]
6. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031 [TBL] [Abstract][Full Text] [Related]
7. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Broadbent V; Pritchard J; Yeomans E Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842 [TBL] [Abstract][Full Text] [Related]
8. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Viana MB; Oliveira BM; Silva CM; Rios Leite VH Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481 [TBL] [Abstract][Full Text] [Related]
9. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study. Duan MH; Han X; Li J; Zhang W; Zhu TN; Han B; Zhuang JL; Wang SJ; Cao XX; Cai HC; Chen M; Yang C; Zhou DB Leuk Res; 2016 Mar; 42():43-6. PubMed ID: 26859782 [TBL] [Abstract][Full Text] [Related]
10. [Treatment results of Langerhans cell histiocytosis with LSH II protocol]. Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide. Yu LC; Shenoy S; Ward K; Warrier RP Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350 [TBL] [Abstract][Full Text] [Related]
12. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience. Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients]. Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165 [TBL] [Abstract][Full Text] [Related]
14. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India. Narula G; Pradhan ND; Arora B; Banavali SD Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864 [TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489 [TBL] [Abstract][Full Text] [Related]
17. Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis. Lindahl LM; Fenger-Grøn M; Iversen L Br J Dermatol; 2012 Mar; 166(3):642-5. PubMed ID: 21967132 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine. Dimopoulos MA; Theodorakis M; Kostis E; Papadimitris C; Moulopoulos LA; Anastasiou-Nana M Leuk Lymphoma; 1997 Mar; 25(1-2):187-9. PubMed ID: 9130627 [TBL] [Abstract][Full Text] [Related]
20. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC. Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]